Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market
Holding ACTU?
Track your performance easily

Actuate Therapeutics, Inc. (ACTU) Income Statement

6 Followers

Actuate Therapeutics, Inc. Income Statement

Last quarter (Q ), Actuate Therapeutics, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q, Actuate Therapeutics, Inc.'s net income was $-8.30M. See Actuate Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
$ 24.97M
Operating Income
$ -24.97M
Net Non Operating Interest Income Expense
$ 309.03K
Other Income Expense
$ 79.82K
Pretax Income
$ -24.74M
Tax Provision
-
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -24.74M
Basic EPS
$ -17.24
Diluted EPS
$ -17.24
Basic Average Shares
$ 1.43M
Diluted Average Shares
$ 1.43M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 24.97M
Net Income From Continuing And Discontinued Operation
$ -24.74M
Normalized Income
$ -18.19M
Interest Expense
-
EBIT
$ -24.70M
EBITDA
$ -24.70M
Currency in USD

Actuate Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis